Smith, Moore & Co’s Clorox CLX Stock Holding History

Smith, Moore & Co’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,546	Closed	-$204K	–	305
2017 Q3	$204K	Buy	+1,546	New	+$208K	0.06%	284

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VAM

ValueInvest Asset Management Luxembourg $1.47B AUM 0.87% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Smith, Moore & Co's CLX Position: Q4 2017 in Review

Smith, Moore & Co sold out of Clorox (CLX) in Q4 2017, closing a stake of 1,546 shares — an estimated $204K sold.

Smith, Moore & Co first reported a position in CLX in Q3 2017 and held it in 1 quarter. The position peaked at $204K in Q3 2017. 932 funds tracked by Wall St. Rank hold CLX as of Q4 2017.

Smith, Moore & Co reported no remaining Clorox position as of Q4 2017 after selling out during the quarter.
Smith, Moore & Co sold 1,546 Clorox shares in Q4 2017, an estimated $204K.
Smith, Moore & Co first reported a position in Clorox in Q3 2017 and held it in 1 quarter.
Smith, Moore & Co's Clorox position peaked at $204K in Q3 2017.
932 funds tracked by Wall St. Rank held Clorox as of Q4 2017.

Based on Smith, Moore & Co's 13F filing for Q4 2017, filed 9 Feb 2018.